Hostname: page-component-586b7cd67f-2plfb Total loading time: 0 Render date: 2024-11-26T23:31:17.925Z Has data issue: false hasContentIssue false
  • English
  • Français

Central effects of peripherally administrated immune cells modulated by a psychoactive substance in aggression

Published online by Cambridge University Press:  27 August 2024

E. Markova ,
E. Serenko ,
M. Knyazheva ,
A. Akopyan ,
M. Tikhonova  and
T. Amstislavskaya
E. Markova*
Affiliation:
1Neuroimmunology Lab, State Research Institute of Fundamental and Clinical Immunology
E. Serenko
Affiliation:
1Neuroimmunology Lab, State Research Institute of Fundamental and Clinical Immunology
M. Knyazheva
Affiliation:
1Neuroimmunology Lab, State Research Institute of Fundamental and Clinical Immunology
A. Akopyan
Affiliation:
2State Research Institute of Neurosciences and Medicine, Novosibirsk, Russian Federation
M. Tikhonova
Affiliation:
2State Research Institute of Neurosciences and Medicine, Novosibirsk, Russian Federation
T. Amstislavskaya
Affiliation:
2State Research Institute of Neurosciences and Medicine, Novosibirsk, Russian Federation
*
*Corresponding author.

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Introduction

It is known that the formation of aggressive behavior is accompanied by neurodegenerative and neuroinflammatory changes. Immune cells have a regulatory effect on the central nervous system functions, including regulation of behavior.

Objectives

We first demonstrated that ex vivo chlorpromazine - modulated immune cells have a positive aggressive behavior editing effect. The aim of the study was to investigate the influence of the indicated cells on some central mechanisms underlying the development of aggressive reactions.

Methods

(CBAxC57Bl/6) F1 aggressive male mice, developed in conditions of chronic social stress, were undergoing the transplantation of syngeneic spleen lymphocytes with ex vivo chlorpromazine-modulated functional activity. In recipients the immunohistochemical analysis was performed assessing the expression of the microglial marker Iba1. The levels of brain-derived neurotrophic factor (Bdnf) and cytokines was assessed by ELISA. For histological examination Nissl staining was applied.

Results

Aggressive behavior editing after the chlorpromazine-modulated immune cells transplantation registered against the background of some structural and functional changes in the brain. It was found an increase in the density of pyramidal neurons in CA1 and CA3 hippocampal regions and augmented level of Bdnf. The decreased expression of microglial activation marker Iba1, accompanied with decreased levels of pro-inflammatory cytokines (IL-1β, IL-2, IL-6, INF-γ) and increased  anti-inflammatory (IL-4) cytokine was found. Visualization of functionally active lymphocytes pre-treated with chlorpromazine in the brain parenchyma of aggressive recipients suggests a direct effect of injected lymphocytes on CNS.

Conclusions

The effect of chlorpromazine - modulated immune cells that edits aggressive behavior is realized by stimulating neurogenesis, neuroplasticity and reducing neuroinflammation.

Disclosure of Interest

None Declared

Type
Abstract
Information
European Psychiatry , Volume 67 , Special Issue S1: Abstracts of the 32nd European Congress of Psychiatry , April 2024 , pp. S683
Creative Commons
Creative Common License - CCCreative Common License - BY
This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
Copyright
© The Author(s), 2024. Published by Cambridge University Press on behalf of European Psychiatric Association
Submit a response

Comments

No Comments have been published for this article.